72 累计需求单数
¥3,112,780.0 累计需求金额
0 违规次数

10000美金,寻求一份聚合物粘结剂理论报告。

悬赏
未托管赏金
¥0.00
  1. 发布需求
  2. 药智客交稿
  3. 任务主选稿中
  4. 验收与付款
  1. 任务结束
任务结束
交易模式:
单人中标
赏金分配:
一人独享赏金,¥0
具体要求:
寻找一种可以代替粘结剂(胶水)粘结聚合材料的方法,聚合材料如:织物,橡胶,泡沫或胶片。粘合效果必须是长久有效的,并且优于粘合剂如:性价比,快速粘合时间。 投标截止时期2016年5月30日, 投标网址:https://www.innocentive.com/ar/challenge/9933860 Bonding of Polymeric Materials without Adhesives TAGS:CChemistry \\ Physical Sciences \\ Engineering \\ Design \\ Royal Society of Chemistry AWARD: $10,000 USD | DEADLINE: 5/30/16 | ACTIVE SOLVERS: 123 | POSTED: 4/28/16 The Seeker is looking for alternative methods to bond specific polymeric materials together other than adhesives. These polymeric materials can be in many forms including fabrics, rubber, foams and films. The bond must be durable and offer advantages over adhesives like cost and time savings. This Theoretical Challenge requires only a written proposal. Source: InnoCentive Challenge ID: 9933860 Sign Agreement For This Challenge By electronically signing the agreement below, you are indicating your intention to view the details of this specific InnoCentive Challenge. Viewing the Challenge Details does not obligate you to perform any work on this challenge. Print this Agreement for your records InnoCentive Theoretical (IP Rights Transfer) Challenge-Specific Agreement Please Read This Carefully! You and InnoCentive are agreeing to a Challenge-Specific Solver Agreement for this particular InnoCentive Challenge only, as permitted in the Terms of Use. The Seeker for this InnoCentive Challenge has required that you accept these special terms, so please take the time to understand them. If you click \\"I agree\\" and proceed to the Project Room for this InnoCentive Challenge, this Challenge-Specific Agreement (\\"CSA\\") will be a valid and binding agreement for all purposes relating to this InnoCentive Challenge and in addition to your agreement to abide by the Terms of Use when you registered as a Solver. Please print and keep a copy of this CSA. No provisions you may have agreed to that are specific to any other individual InnoCentive Challenge will apply. 1. Your Responsibility to Avoid Obstacles. InnoCentive needs to know that if you solve the InnoCentive Challenge there will not be any legal obstacles to completing the sale and assignment of your rights to InnoCentive (which will, in turn, assign the rights to the Seeker), which is the only way that you can receive the Award. You agree to be responsible for avoiding obstacles to transferring all Intellectual Property and Work Product (altogether, the \\"Solution IP\\") if you submit a Proposed Solution chosen as a Solution. IT IS YOUR RESPONSIBILITY TO DETERMINE YOUR ABILITY TO TRANSFER THE SOLUTION IP. BY SUBMITTING A PROPOSED SOLUTION, YOU REPRESENT TO INNOCENTIVE AND SEEKER THAT THERE ARE NO OBSTACLES TO SUCH TRANSFER. You will not receive an Award if you cannot transfer the Solution IP. 2. Your Guarantee. You agree that if and when the time comes to transfer the Solution IP, you will give a guarantee (the \\"Guarantee\\") that the transfer is lawful in exchange for the one-time payment of the Award to you alone, and that no consents, waivers, approvals, agreements or contracts that you did not already have before starting the InnoCentive Challenge are necessary from or with anyone else, such as by way of example: a. Your employer (or, if you are a consultant, contracting entity); b. Any former employer or other entity you are or have been associated with or have a contract with regarding Intellectual Property you develop; c. Anyone who collaborated or is collaborating with you on the development of the Solution IP; d. Anyone else whose Intellectual Property you use(d) or incorporate(d) in the Solution IP; e. Anyone who licensed technology or intellectual property to you; f. Any government official, regulatory body or other authority (for example, if any of the Solution IP is within the scope of a technology export control law in your country prohibiting its transfer to InnoCentive in the United States, or if the required assignments or licenses of the Solution IP are otherwise subject to public registration, review and/or approval) g. The holder of any lien (for example, if a bank or other creditor has obtained a mortgage or security interest in any of the Solution IP); h. Anyone who may be entitled to royalties or other payments relating to any of the Solution IP either by law or contract. 3. Your Obligations to Protect Potential Solution IP. In order to be eligible for an Award, during the period from when you begin work on the InnoCentive Challenge until the expiration of the Time Period as set forth in the Challenge Statement, you shall not: a. Grant, license, transfer, and/or assign away any rights in the Work Product or Proposed Solution you are developing (\\"Potential Solution IP\\"), or do anything else that would prevent you from granting the Option for the Exclusivity Period; b. Reveal to any third party, except on terms of strict confidentiality, any information that relates to Potential Solution IP or do anything else likely to impair any of the Potential Solution IP; or c. Do anything that would cause the failure of your Guarantee. You further agree that the identity of any patents or patent applications included in the Potential Solution IP (the “Patents”), any information provided to the Seeker about the Patents, the Seeker’s receipt and/or evaluation of any such information and/or the Patents, and any related discussions between the you and the Seeker (collectively, “Evaluation Activities and Information”) shall not be used as a basis to place the Seeker on notice (e.g., for purposes of willfulness, inducement or otherwise) of the Patents and shall not constitute pre-litigation notice to or knowledge by (or evidence thereof) the Seeker. You agree not to use, and waive the right to use, any Evaluation Activities and Information (including, without limitation, patent numbers) as evidence for any purpose in any judicial, administrative, or other proceeding in which infringement of the patents is alleged against the Seeker. You hereby release and waive all claims for damages based on such Evaluation Activities and Information against the Seeker. Should a claim based on such alleged notice or knowledge be made by you (or your subsequent assignee or another third party) against the Seeker, this CSA may be used by the Seeker to seek to dismiss such a claim. You shall require that any subsequent purchaser and/or assignee of the Patents is obligated to honor the foregoing covenant. Notwithstanding anything to the contrary in this CSA, the foregoing covenant shall survive expiration or termination of this CSA. 4. Exclusivity Period. By submitting your Proposed Solution you agree to grant to InnoCentive and the Seeker the following rights, for a period of ninety (90) days (the \\"Exclusivity Period\\") from the deadline set forth in the InnoCentive Challenge Statement (the \\"Deadline\\"): (a) an exclusive option to acquire the rights to the Proposed Solution for use in connection with the InnoCentive Challenge (the \\"Option\\"), as described in this Agreement, and (b) a non-exclusive, worldwide license to use, copy, distribute and create derivative works of the Proposed Solution and the associated work product (the \\"Work Product\\") for purposes of review, analysis and testing the Proposed Solution on a theoretical basis (collectively, these nonexclusive rights and the Option are referred to as the \\"Exclusive Option Rights\\"). InnoCentive will make reasonable efforts to transmit relevant Proposed Solutions to Seekers, however, nothing herein shall be construed as requiring InnoCentive to transmit every Proposed Solution submitted in an InnoCentive Challenge to a Seeker. In addition, by submitting your Proposed Solution you thereby agree to provide reasonable assistance and additional information concerning Work Product and your Proposed Solution to InnoCentive and/or the Seeker during the Exclusivity Period, if requested. By granting the Exclusive Option Rights you agree that during the Exclusivity Period (and thereafter, if the Option is exercised), you are prohibited from (x) using the Proposed Solution or the Work Product or (y) disclosing to or granting or assigning or transferring any rights to a third party to use the Proposed Solution and/or the Solution IP for any purpose, including the application for patents or similar intellectual property rights. 5. Acceptance of Proposed Solution and Transfer of Intellectual Property. InnoCentive will notify you within a commercially reasonable period of time after the Deadline and before the termination of the Exclusivity Period whether a Seeker accepts your Proposed Solution and wishes to exercise an Option (\\"Acceptance\\"). For purposes of this Agreement, \\"Acceptance\\" shall mean the selection of your Proposed Solution by the Seeker as meeting the Solution Acceptance Criteria as set forth in the InnoCentive Challenge Statement. The Seeker has absolute and sole discretion to determine whether to Accept your Proposed Solution, or any Proposed Solution, and whether to make an Award, multiple Awards or any Award. Solver acknowledges and agrees that InnoCentive is not responsible for and has no liability for selection of a winning solver, if any. Solver further agrees to hold InnoCentive legally harmless in regard to selection of a winning solver, if any. Solver agrees to hold InnoCentive legally harmless for any advice it may provide as to the quality or suitability of submitted solutions and agrees to waive any claim against InnoCentive for Solver\'s failure to win an award. The meeting of the Solution Acceptance Criteria does not mean that the Proposed Solution will be Accepted by a Seeker. In the event that your Proposed Solution is not Accepted within the Exclusivity Period, the Exclusive Option Rights will terminate without further notice to you and Seeker will retain no rights to the Proposed Solution or the Work Product. Upon Acceptance of your Proposed Solution by a Seeker and payment of an Award to you (see \\"Payments\\"), you hereby assign and convey to InnoCentive, as escrow agent for Seeker, all rights, title, and interests in and to the Proposed Solution and any Work Product that are related to the InnoCentive Challenge, and you retain no rights to the Proposed Solution or the Work Product insofar as they are related to the InnoCentive Challenge. In the event that the Work Product cannot be assigned and conveyed under statutory law, you herewith grant to InnoCentive, as escrow agent for Seeker, a worldwide, unlimited, perpetual, irrevocable, and exclusive license to use, make, have made, market, copy, modify, lease, sell, distribute, and create derivative works of the Work Product, including the right to assign the foregoing license to Seekers (all such rights collectively referred to as \\"Intellectual Property\\"). If you utilize any processes in development of the Work Product which are the subject of patent rights owned by you, you agree to grant to InnoCentive, as escrow agent for Seeker, a worldwide, non-exclusive, perpetual, royalty-free right and license to practice any patented processes used in the Work Product, including the right to sublicense the foregoing to the Seeker. Furthermore, you agree that you will, during the term of this Agreement and at any time thereafter, execute all papers and do all things deemed necessary by InnoCentive or a Seeker to ensure that the Seeker acquires all rights, title, and interests in and to the Solution and any Work Product that are related to the InnoCentive Challenge, including the rights to all Intellectual Property embodied therein, and that ensures that all such rights are transferred to the Seeker (the foregoing obligations referred to as the “Continuing Obligations”). Such cooperation and execution shall be performed without additional compensation to you; provided, however, InnoCentive shall reimburse you for reasonable out-of-pocket expenses incurred at the specific request of InnoCentive. Upon payment of the Award, or termination of the Exclusive Option Rights for any reason, there will be no further obligations between you and InnoCentive or the Seeker with respect to the Proposed Solution, the Work Product, or the InnoCentive Challenge, except for the Continuing Obligations and the limitations on use and disclosure described under \\"Confidentiality\\", below. 6. Escrows. The transfers of Solution IP and the Award or any Revised Award Amount (as determined by Seeker) will be managed in escrow and administered by InnoCentive as follows: a. Your transfer of the Solution IP will be to InnoCentive as escrow agent for the Seeker. The Solution IP will be released from this escrow and transferred by InnoCentive to the Seeker upon the occurrence of each of the following: (a) the completion of InnoCentive\'s verification of you; (b) the Seeker\'s payment of the Award to InnoCentive; and (c) the Seeker\'s payment of any other fees of InnoCentive pursuant to the separate agreement between the Seeker and InnoCentive. b. The Seeker\'s payment of the Award will be to InnoCentive as escrow agent for you. The Award will be released from this escrow and transferred to you by InnoCentive as soon as payment is due to you as set forth below in “Payments”. 7. Payments. If a Seeker Accepts your Proposed Solution, the payment amount (called an \\"Award\\") specified in the InnoCentive Challenge posted on the Service by a Seeker (or, in the case of partial payments of Awards, a \\"Revised Award Amount\\", if applicable) shall be paid to you by InnoCentive within thirty (30) days after the occurrence of each of the following: (1) you are notified by lnnoCentive of your Proposed Solution’s Acceptance; (2) the completion of certain verification procedures by InnoCentive, and review and acceptance of such results by the Seeker; and *3) InnoCentive’s receipt of Award payment from the Seeker. Payment of any Award is conditioned upon your cooperation with InnoCentive\'s verification procedures. The Award will be paid to you locally, in U.S. Dollars, or if required by your local law, in your local currency equivalent based on the foreign exchange rate in effect on the date of the disbursement by InnoCentive. InnoCentive is not responsible for payment of any Award, or any part of any Award, to any party other than to the Solver through whom the Proposed Solution was submitted to the Service. You understand that the Award represents a complete payment, net of any local taxes that InnoCentive may be required to withhold, for any Accepted Proposed Solution and that you are not entitled to any other compensation of any kind. If local law does not require withholding of taxes, all taxes on Awards shall be your sole responsibility. 8. Confidentiality. During the term of this Agreement and at all times thereafter, you shall not disclose to any third party nor use for any purpose other than for the performance of this Agreement, any Confidential Information (as defined below) without the express written consent of the owner of the Confidential Information. These confidentiality obligations shall not apply to Confidential Information which: (a) is in the public domain, or which was publicly known or available on the date you originally accepted this Agreement (\\"Effective Date\\"); or (b) after the Effective Date becomes available to the public in a manner not involving a breach of any duty under this Agreement. Nothing herein shall preclude the ultimate disclosure of any information required by law. \\"Confidential Information\\" includes: • All information set forth in the password protected areas and Project Rooms of the Service (\\"Service Information\\"), (the presentation of Service Information via the Service shall not be deemed to be a public disclosure for purposes of this Agreement and shall not operate as an exclusion from Confidential Information); and • During any Exclusivity Period and after Acceptance and exercise of an Option relating to a InnoCentive Challenge, any Work Product or Proposed Solution relating to said InnoCentive Challenge. The same restrictions on disclosure and use of Confidential Information described in this Section shall apply to the use or disclosure by InnoCentive and Seekers of any Work Product or Proposed Solution during the Exclusivity Period and, if the Proposed Solution is not accepted, thereafter, unless the Proposed Solution or Work Product can be shown by business records of Seeker or InnoCentive to (1) have been known to them previously; (2) is independently created by personnel of Seeker who had no access to the Proposed Solution or the Work Product; or (3) is subject to the exceptions to Confidentiality in (a) or (b) of this section; provided, however, notwithstanding the foregoing, nothing in this Solver Agreement shall prevent a Seeker from utilizing a Solution, for which an Award has been paid, to the extent that a Solution and any rejected Proposed Solution contain overlapping Work Product. Notwithstanding anything herein to the contrary, you recognize that other persons, including Seeker, may have independently developed and/or provided to Seeker or others, or made public, or may in the future submit, or make public, materials that are the same or similar to your Proposed Solution. You acknowledge and agree that Seeker shall have the right to use such same or similar materials, and that you will not be entitled to any compensation arising from Seeker\'s use of such materials. 9. General Conditions: InnoCentive and/or Seeker has the right to verify each Solver\'s eligibility and compliance with this CSA, and to terminate any Solver\'s registration and participation in a Challenge on the basis of its investigation. Personal data will be processed in accordance with InnoCentive\'s Privacy Policy which can be located at http://www.innocentive.com/privacy.php. Solvers should direct any request to access, update, or correct information to InnoCentive. Neither InnoCentive nor Seeker is responsible for human error, theft, destruction, or damage to Proposed Solutions, or other factors beyond its reasonable control. 10. Third Party Beneficiary. You and InnoCentive acknowledge and agree that any Seeker shall be a third-party beneficiary of this Agreement, and each shall have the right to assert and enforce the provisions of this Agreement directly on its own behalf. 11. Conflict. In the case of any conflict between the terms of this CSA and the Terms of Use, this CSA controls.
2016-05-13 15:59
0条新稿件,点击看看
  • chacca

    您好,我有相关信息,请您联系我

    2016-05-13 17:24 IP:重庆 参与编号 # 评论 举报
    数据载入中....
    发言请遵守"七条底线",还可以输入140个字

当前为付费需求,赏金分配方式:一人独享赏金。

任务主在众多备选稿件中选择最满意的稿件,支付赏金。

托管赏金,保障各方权益:

任务主把所发需求的悬赏金托管到药智网指定账户,以激发众多药智客的参与热情,保障任务主尽快征集到满意稿件;

同时,赏金托管也是为了保障参与挑战的药智客的正当权益。

流程说明:

发布需求

点击“发布需求”按钮,按照流程引导,将需求详情、具体要求描述清楚,发布到药智网的药智汇平台。

托管赏金

为征集到满意稿件,任务主须做好“赏金预算”,并将赏金托管到药智网指定账户,打消药智客的顾虑,激励药智客积极参与需求挑战。

药智客参与

任务主托管赏金后,所发布的需求显示“赏金已托管”字样。只有托管了悬赏金的需求,能够鼓舞众多的药智客参与,获取到满意的稿件!

选择满意稿件

任务主在众多参与者提交的稿件中,选择符合任务主需求的稿件。再通过互动,选择任务主最满意的稿件,并确定其为中标稿件。

验收与付款

中标稿件提交任务主验收。任务主在验收/验证期内,完成验收/验证工作。对合格稿件,通知药智网支付佣金。

评价

双方可以针对本次交易各自的表现进行评价,评价结果将影响各自的信用度和能力值。

类似的需求

    加载数据中...

该需求者还有这些需求

    加载数据中...

推荐需求

    加载数据中...
感兴趣,就投稿吧!投的越早,中标几率就越大! 收藏
挖掘医药数据,分享医药情报
扫一扫,关注药智数据公众号

2014 药智再发力 我们换装了!!

为了让您有更好的体验,药智对用户体系和产品进行了全新升级!

我要看看